Study of drug-drug interaction between loperamide and α2 adrenergic receptor agonists in rodents

M. K. Yadav, L. M.D. Ahmed, V. N. Rao, K. Nandakumar, S. M. Shantha Kumar

Research output: Contribution to journalArticle

Abstract

To investigate any alteration in antidiarrhoeal activity of loperamide on concomitant administration with α2 agonists like methyldopa, clonidine or tizanidine in rodents. Diarrhoea was induced in rats by (1) administration of castor oil (1 mL/100 g) or (2) prostaglandin E2 (100 mcg/kg). Loperamide or α2 agonists individually or their combinations were administered one hour before induction of diarrhoea in rats. Antimotility effect of these drugs was studied by charcoal meal test in mice. The interaction of loperamide with α2 agonists was studied in these models. In castor oil and PGE2 induced diarrhoea loperamide, clonidine, tizanidine significantly inhibited the faecal mass and secretions. Combination of loperamide with clonidine or tizanidine potentiated the antidiarrhoeal effect of loperamide in these models. Methyldopa did not produce any antidiarrhoeal effect when administered alone. On combination with loperamide it inhibited the antidiarrhoeal action of loperamide. In charcoal meal test, the antimotility effect of loperamide was not altered by clonidine or tizanidine co-administration. While combination of methyldopa with loperamide, inhibited the antimotility effect of loperamide. The present study revealed that the antidiarrhoeal effect of loperamide was potentiated by tizanidine and clonidine. However, methyldopa inhibited the antidiarrhoeal effect of loperamide.

Original languageEnglish
Pages (from-to)346-351
Number of pages6
JournalIndian Drugs
Volume44
Issue number5
Publication statusPublished - 01-05-2007

Fingerprint

Loperamide
Adrenergic Agonists
Drug Interactions
Rodentia
Antidiarrheals
Pharmaceutical Preparations
Clonidine
Methyldopa
Castor Oil
Diarrhea
Charcoal
Dinoprostone
Meals

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Yadav, M. K., Ahmed, L. M. D., Rao, V. N., Nandakumar, K., & Shantha Kumar, S. M. (2007). Study of drug-drug interaction between loperamide and α2 adrenergic receptor agonists in rodents. Indian Drugs, 44(5), 346-351.
Yadav, M. K. ; Ahmed, L. M.D. ; Rao, V. N. ; Nandakumar, K. ; Shantha Kumar, S. M. / Study of drug-drug interaction between loperamide and α2 adrenergic receptor agonists in rodents. In: Indian Drugs. 2007 ; Vol. 44, No. 5. pp. 346-351.
@article{7cc880d7216c47ef9b950ff63dce4ef5,
title = "Study of drug-drug interaction between loperamide and α2 adrenergic receptor agonists in rodents",
abstract = "To investigate any alteration in antidiarrhoeal activity of loperamide on concomitant administration with α2 agonists like methyldopa, clonidine or tizanidine in rodents. Diarrhoea was induced in rats by (1) administration of castor oil (1 mL/100 g) or (2) prostaglandin E2 (100 mcg/kg). Loperamide or α2 agonists individually or their combinations were administered one hour before induction of diarrhoea in rats. Antimotility effect of these drugs was studied by charcoal meal test in mice. The interaction of loperamide with α2 agonists was studied in these models. In castor oil and PGE2 induced diarrhoea loperamide, clonidine, tizanidine significantly inhibited the faecal mass and secretions. Combination of loperamide with clonidine or tizanidine potentiated the antidiarrhoeal effect of loperamide in these models. Methyldopa did not produce any antidiarrhoeal effect when administered alone. On combination with loperamide it inhibited the antidiarrhoeal action of loperamide. In charcoal meal test, the antimotility effect of loperamide was not altered by clonidine or tizanidine co-administration. While combination of methyldopa with loperamide, inhibited the antimotility effect of loperamide. The present study revealed that the antidiarrhoeal effect of loperamide was potentiated by tizanidine and clonidine. However, methyldopa inhibited the antidiarrhoeal effect of loperamide.",
author = "Yadav, {M. K.} and Ahmed, {L. M.D.} and Rao, {V. N.} and K. Nandakumar and {Shantha Kumar}, {S. M.}",
year = "2007",
month = "5",
day = "1",
language = "English",
volume = "44",
pages = "346--351",
journal = "Indian Drugs",
issn = "0019-462X",
publisher = "Indian Drug Manufacturers' Association",
number = "5",

}

Yadav, MK, Ahmed, LMD, Rao, VN, Nandakumar, K & Shantha Kumar, SM 2007, 'Study of drug-drug interaction between loperamide and α2 adrenergic receptor agonists in rodents', Indian Drugs, vol. 44, no. 5, pp. 346-351.

Study of drug-drug interaction between loperamide and α2 adrenergic receptor agonists in rodents. / Yadav, M. K.; Ahmed, L. M.D.; Rao, V. N.; Nandakumar, K.; Shantha Kumar, S. M.

In: Indian Drugs, Vol. 44, No. 5, 01.05.2007, p. 346-351.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Study of drug-drug interaction between loperamide and α2 adrenergic receptor agonists in rodents

AU - Yadav, M. K.

AU - Ahmed, L. M.D.

AU - Rao, V. N.

AU - Nandakumar, K.

AU - Shantha Kumar, S. M.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - To investigate any alteration in antidiarrhoeal activity of loperamide on concomitant administration with α2 agonists like methyldopa, clonidine or tizanidine in rodents. Diarrhoea was induced in rats by (1) administration of castor oil (1 mL/100 g) or (2) prostaglandin E2 (100 mcg/kg). Loperamide or α2 agonists individually or their combinations were administered one hour before induction of diarrhoea in rats. Antimotility effect of these drugs was studied by charcoal meal test in mice. The interaction of loperamide with α2 agonists was studied in these models. In castor oil and PGE2 induced diarrhoea loperamide, clonidine, tizanidine significantly inhibited the faecal mass and secretions. Combination of loperamide with clonidine or tizanidine potentiated the antidiarrhoeal effect of loperamide in these models. Methyldopa did not produce any antidiarrhoeal effect when administered alone. On combination with loperamide it inhibited the antidiarrhoeal action of loperamide. In charcoal meal test, the antimotility effect of loperamide was not altered by clonidine or tizanidine co-administration. While combination of methyldopa with loperamide, inhibited the antimotility effect of loperamide. The present study revealed that the antidiarrhoeal effect of loperamide was potentiated by tizanidine and clonidine. However, methyldopa inhibited the antidiarrhoeal effect of loperamide.

AB - To investigate any alteration in antidiarrhoeal activity of loperamide on concomitant administration with α2 agonists like methyldopa, clonidine or tizanidine in rodents. Diarrhoea was induced in rats by (1) administration of castor oil (1 mL/100 g) or (2) prostaglandin E2 (100 mcg/kg). Loperamide or α2 agonists individually or their combinations were administered one hour before induction of diarrhoea in rats. Antimotility effect of these drugs was studied by charcoal meal test in mice. The interaction of loperamide with α2 agonists was studied in these models. In castor oil and PGE2 induced diarrhoea loperamide, clonidine, tizanidine significantly inhibited the faecal mass and secretions. Combination of loperamide with clonidine or tizanidine potentiated the antidiarrhoeal effect of loperamide in these models. Methyldopa did not produce any antidiarrhoeal effect when administered alone. On combination with loperamide it inhibited the antidiarrhoeal action of loperamide. In charcoal meal test, the antimotility effect of loperamide was not altered by clonidine or tizanidine co-administration. While combination of methyldopa with loperamide, inhibited the antimotility effect of loperamide. The present study revealed that the antidiarrhoeal effect of loperamide was potentiated by tizanidine and clonidine. However, methyldopa inhibited the antidiarrhoeal effect of loperamide.

UR - http://www.scopus.com/inward/record.url?scp=79251590761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251590761&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 346

EP - 351

JO - Indian Drugs

JF - Indian Drugs

SN - 0019-462X

IS - 5

ER -